Article
Amiloride Modulates Alternative Splicing in Leukemic Cells and Resensitizes Bcr-Abl T315I Mutant Cells to Imatinib
11 Jan 2011
Abstract excerpt
The antihypertensive drug amiloride is being considered as a tactic to improve cancer therapy including that for chronic myelogenous leukemia. In this study, we show that amiloride modulates the alternative splicing of various cancer genes, including Bcl-x, HIPK3, and BCR/ABL, and that this effect is not mainly related to pH alteration, which is a known effect of the drug. Splice modulation involved various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
